Deep Learning for Pancreas Segmentation: a Systematic Review

TL;DR

This systematic review comprehensively analyzes deep learning methods for pancreas segmentation, highlighting technical approaches, datasets, and challenges, and discusses future directions for clinical application.

Contribution

It provides a detailed overview of recent deep learning techniques, datasets, and challenges in pancreas segmentation, offering insights for future research and clinical translation.

Findings

Deep learning models have advanced pancreas segmentation accuracy.

Challenges include dataset variability and boundary ambiguity.

Future work should focus on generalization and clinical validation.

Abstract

Pancreas segmentation has been traditionally challenging due to its small size in computed tomography abdominal volumes, high variability of shape and positions among patients, and blurred boundaries due to low contrast between the pancreas and surrounding organs. Many deep learning models for pancreas segmentation have been proposed in the past few years. We present a thorough systematic review based on the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. The literature search was conducted on PubMed, Web of Science, Scopus, and IEEE Xplore on original studies published in peer-reviewed journals from 2013 to 2023. Overall, 130 studies were retrieved. We initially provided an overview of the technical background of the most common network architectures and publicly available datasets. Then, the analysis of the studies combining visual presentation in tabular form and text description was reported. The tables grouped the studies specifying the application, dataset size, design (model architecture, learning strategy, and loss function), results, and main contributions. We first analyzed the studies focusing on parenchyma segmentation using coarse-to-fine approaches, multi-organ segmentation, semi-supervised learning, and unsupervised learning, followed by those studies on generalization to other datasets and those concerning the design of new loss functions. Then, we analyzed the studies on segmentation of tumors, cysts, and inflammation reporting multi-stage methods, semi-supervised learning, generalization to other datasets, and design of new loss functions. Finally, we provided a critical discussion on the subject based on the published evidence underlining current issues that need to be addressed before clinical translation.